Beijing Kefruide Technology Development Co., Ltd. is a high-tech enterprise specializing in the development and production of active pharmaceutical ingredients (APIs) and synthetic intermediates, while also providing contract customization services for clients. The company's sales headquarters is located in Beijing, the capital of China, with independent R&D and production bases in Hebei and Shandong provinces, offering a geographically advantageous position.
The company employs over ten key research personnel, all holding bachelor's or master's degrees, with extensive industry experience and strong technical expertise. It is committed to advancing the industrialization of frontline pharmaceuticals and the research and development of innovative drugs. The company has established extensive project collaborations with numerous well-known domestic pharmaceutical manufacturers, research institutions, and universities. Additionally, it actively cooperates with pharmaceutical companies in India, Pakistan, the United States, Poland, and other countries to promote new drug R&D initiatives, develop advanced technological processes for drug R&D and production, and expand into international markets.
The company focuses on developing globally outstanding pharmaceutical products, with key areas including anti-tumor drugs, anti-infectives, anti-diabetic agents, and medications for the nervous, hepatic, and biliary systems. Leveraging the management and R&D team's deep understanding and control of drug development risks and GMP standards, the company has developed a series of trustworthy drug preparation processes.
Product quality is regarded as the lifeblood of the enterprise. Upholding a pioneering, enterprising, honest, and pragmatic work ethic, along with a customer-first philosophy, the company provides reliable products and services with professional expertise.
